StockData
Biotricity Inc. logo

Biotricity Inc. (BTCY) shareholders

BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 4/30
$0.05+0.00 (+8.70%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.2%
0M of 20M shares
Institutional holders
1
0 new, 1 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Ionic Ventures, LLC
Joint filing with Ionic Management, LLC (9.90%), Brendan O'Neil (9.90%) and 1 more
3,241,7709.90%13G (passive) amendmentJun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of BTCYValueChange% of portfolio
Strengthening Families & Communities, LLC48,2630.24%$5.99K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202610M0.2%0 / 00 / 10M0M
Q1 202620M0.3%1 / 00 / 00M0M
Q4 202510M0.1%1 / 00 / 10M0M
Q3 202510M0.2%1 / 00 / 00M0M
Q4 202400M0.0%0 / 00 / 40M0M
Q3 202440M0.3%1 / 00 / 160M0M
Q2 2024200M2.4%6 / 33 / 20M0M
Q1 2024160M1.8%1 / 23 / 50M0M
Q4 2023200M1.8%3 / 35 / 40M0M
Q3 2023211M2.5%21 / 00 / 01M0M

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Norman M. Betts
Director
Nov 29, 2021Award+54,348––375,598
David A. Rosa
Director
Nov 29, 2021Award+27,174––152,174
David A. Rosa
Director
Oct 11, 2021Sale−3,318$3.05$10.12K125,000
David A. Rosa
Director
Oct 8, 2021Sale−9,481$3.20$30.34K128,318
David A. Rosa
Director
Oct 7, 2021Sale−17,228$3.08$53.06K137,799
David A. Rosa
Director
Sep 16, 2021Sale−34,977$3.43$119.97K155,027
David A. Rosa
Director
Sep 15, 2021Sale−6,246$3.27$20.42K190,004
Patricia J. Kennedy
Director
Apr 7, 2020Award+125,000––250,000
Norman M. Betts
Director
Apr 7, 2020Award+125,000––321,250

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-0.3%
From 0M shares
Short volume, 20 days
46.1%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Biotricity's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,170 shares on Oct 7, 2026 over the last 90 days.

See a number that looks wrong?